Also, the relation between BRCA1 mRNA and cisplatin-based neoadjuvant chemotherapy was studied [8] and emphasized that the detection of BRCA1 mRNA expression could estimate both the sensitivity to chemotherapy and prognosis among patients with bladder cancer [8]. Here, BRCA1 is linked to urinary bladder carcinoma.